骨髓来源的内皮祖细胞改善内皮功能，并且能预测心血管风险。
Bone marrow-derived endothelial progenitor cells (EPC) improve vascular function and predict cardiovascular risk.
这使得他们能够区分骨髓来源的内皮祖细胞和其他组织来源的内皮细胞。
This enabled them to differentiate EPCs that originated in the bone marrow from endothelial cells that are found in normal tissues throughout the body.
我们同样检测来源于骨髓的循环祖细胞的CD 34 + CD 133 +丛族数量，作为血管再生和内皮活动能力指数。
We also quantified the CD34 + CD133 + population of circulating progenitor cells (CPCs) that originate from bone marrow, as an index of hematopoietic and endothelial mobilization capacity.
应用推荐